The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Effect of high MMP2 and low MMP9 baseline serum levels on outcome in patients with HER2-positive inflammatory breast cancer (IBC) treated with bevacizumab (BEV)- and trastuzumab (TRA)-based neoadjuvant chemotherapy (NAC) in the BEVERLY 2 study.
 
Emeline Tabouret
No Relationships to Disclose
 
Anthony Goncalves
Honoraria - Eisai; Roche Pharma AG; Sanofi
Consulting or Advisory Role - Roche/Genentech
Research Funding - Roche Pharma AG (Inst)
Travel, Accommodations, Expenses - Amgen; Novartis; Roche Pharma AG
 
Francois Bertucci
No Relationships to Disclose
 
Jean-Yves Pierga
Consulting or Advisory Role - Roche/Genentech
 
Thierry Petit
No Relationships to Disclose
 
Christelle Levy
No Relationships to Disclose
 
Jean-Marc Ferrero
Honoraria - Roche Pharma AG
 
Mario Campone
Consulting or Advisory Role - Menarini; Novartis; SERVIER
Speakers' Bureau - Novartis
Research Funding - Novartis
 
Joseph Gligorov
Honoraria - Roche Pharma AG
 
Florence Lerebours
No Relationships to Disclose
 
Henri Hubert Roche
No Relationships to Disclose
 
Thomas Denis Bachelot
Consulting or Advisory Role - Roche Pharma AG
Research Funding - Roche Pharma AG (Inst)
 
Yves Toiron
No Relationships to Disclose
 
Jean-Paul Borg
No Relationships to Disclose
 
Olivier L. Chinot
Consulting or Advisory Role - Roche/Genentech
 
Patrice Viens
No Relationships to Disclose